Claritev Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $994.7M+6.9% YoYTTM through 30 Jun 2026
Net Income -$283.1MTTM through 30 Jun 2026
Free Cash Flow -$17.9MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 71.8% |
| EBITDA Margin | 48.0% |
| Operating Margin | 2.7% |
| Net Margin | -28.5% |
Returns
96.1%ROE
-5.9%ROA
-6.5%ROIC
Balance Sheet Health
Debt / Equity-20.11x
Current Ratio1.00x
Net Debt$4.7B
Cash & Equivalents$14.4M
Quality Metrics
Altman Z-Score-0.46
Piotroski F-Score4 / 9
FCF Margin-1.8%
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $965.4M
Diluted EPS-$17.00TTMFY2025: $-17.30
Dividend
No dividend
Capital Allocation
Capex Intensity15.2%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.